| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.4 |